Leiden University Scholarly Publications

Tamoxifen pharmacokinetics and pharmacodynamics in older patients with non-metastatic breast cancer

Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen

Exposure-response analysis of endoxifen serum concentrations in early-breast cancer

Breast cancer outcome in relation to bone mineral density and bisphosphonate use

Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancer

Treatment decisions and the impact of adverse events before and during extended endocrine therapy in postmenopausal early breast cancer

Tailoring adjuvant therapy for hormone receptor-positive breast cancer

The effects of breast cancer therapy on estrogen receptor signaling throughout the body

Extended adjuvant endocrine therapy in hormone-receptor positive early breast cancer: Current and future evidence

Tamoxifen metabolism and pharmacogenetics in breast cancer

Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study

Which factors should be taken into account in perimenopausal women with early breast cancer who may become eligible for an aromatase inhibitor? Recommendations of an expert panel